علاج فرط فوسفات الدم في مرض الكلى المزمن المرحلة الخامسة مع غسيل الكلى وارتفاع الكالسيوم

References

• In CKD stage 5, hypercalcemia can increase the risk of cardiovascular disease.
• Sevelamer and lanthanum can be used in the setting of hypercalcemia, and they offer a cardiovascular mortality benefit.
• In this situation, sevelamer and lanthanum have demonstrated a cardiovascular mortality benefit.
• The target phosphorus concentration for dialysis patients is 3.5 to 5.5 mg/dL.